Xilio Therapeutics Inc (NASDAQ:XLO) shares traded 2.94% higher at $1.05 on Wall Street last session.
XLO stock price is now -8.57% away from the 50-day moving average and -18.71% away from the 200-day moving average. The market capitalization of the company currently stands at $38.76M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $7, Chardan Capital Markets recently initiated with Buy rating for Xilio Therapeutics Inc (NASDAQ: XLO). On January 10, 2022, H.C. Wainwright recently initiated its ‘Buy’ rating on the stock quoting a target price of $36, while ‘Raymond James’ rates the stock as ‘Outperform’
In other news, GILEAD SCIENCES, INC., 10% Owner bought 485,250 shares of the company’s stock on Apr 02 ’24. The stock was bought for $368,790 at an average price of $0.76. Upon completion of the transaction, the 10% Owner now directly owns 7,345,473 shares in the company, valued at $7.71 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 08 ’24, 10% Owner Atlas Venture Fund XI, L.P. sold 733 shares of the business’s stock. A total of $469 was realized by selling the stock at an average price of $0.64. This leaves the insider owning 2,019,563 shares of the company worth $2.12 million. A total of 43.84% of the company’s stock is owned by insiders.
During the past 12 months, Xilio Therapeutics Inc has had a low of $0.49 and a high of $3.25. As of last week, the company has a debt-to-equity ratio of 0.35, a current ratio of 2.19, and a quick ratio of 2.19. The fifty day moving average price for XLO is $1.15666 and a two-hundred day moving average price translates $1.28299 for the stock.
The latest earnings results from Xilio Therapeutics Inc (NASDAQ: XLO) was released for 2024-03-31.
